πŸ‡ΊπŸ‡Έ FDA
Patent

US 9452973

Modulators of the relaxin receptor 1

granted A61PA61P9/00

Quick answer

US patent 9452973 (Modulators of the relaxin receptor 1) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P9/00